221 related articles for article (PubMed ID: 30230397)
1. Completion surgery after chemoradiotherapy for cervical cancer - is there a role? UK Cancer Centre experience of hysterectomy post chemo-radiotherapy treatment for cervical cancer.
Platt SL; Patel A; Humphrey PJ; Al-Booz H; Bailey J
J Obstet Gynaecol; 2019 Jan; 39(1):68-73. PubMed ID: 30230397
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery.
Gui B; Valentini AL; Miccò M; D'Agostino GR; Tagliaferri L; Zannoni GF; Fanfani F; Manfredi R; Bonomo L
Acta Radiol; 2016 Sep; 57(9):1123-31. PubMed ID: 26622060
[TBL] [Abstract][Full Text] [Related]
3. Radical surgery in patients with residual disease after (chemo)radiation for cervical cancer.
Boers A; Arts HJ; Klip H; Nijhuis ER; Pras E; Hollema H; Wisman GB; Nijman HW; Mourits MJ; Reyners AK; de Bock GH; Thomas G; van der Zee AG
Int J Gynecol Cancer; 2014 Sep; 24(7):1276-85. PubMed ID: 24987914
[TBL] [Abstract][Full Text] [Related]
4. Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery.
Yang J; Yang J; Cao D; Shen K; Ma J; Zhang F
J Gynecol Oncol; 2020 Mar; 31(2):e16. PubMed ID: 31912674
[TBL] [Abstract][Full Text] [Related]
5. Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?
Gosset M; Chargari C; Bentivegna E; Leary A; Genestie C; Maulard A; Morice P; Gouy S
Anticancer Res; 2019 Jun; 39(6):2919-2926. PubMed ID: 31177130
[TBL] [Abstract][Full Text] [Related]
6. Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.
Mazeron R; Gouy S; Chargari C; Rivin Del Campo E; Dumas I; Mervoyer A; Genestie C; Bentivegna E; Balleyguier C; Pautier P; Morice P; Haie-Meder C
Radiother Oncol; 2016 Sep; 120(3):460-466. PubMed ID: 27492204
[TBL] [Abstract][Full Text] [Related]
7. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
[TBL] [Abstract][Full Text] [Related]
8. Prognosis impact of posttreatment pelvic MRI in patients treated for stage IB2-IIB cervical cancer with chemoradiation therapy.
Moussilmani T; Knight S; Mancini J; Touboul C; Rodriguez F; Bolze PA; Bendifallah S; Ballester M; Collinet P; Kerbage Y; Ouldamer L; Atrous G; Lavoué V; Dion L; Dabi Y; Raimond E; Graesslin O; Huchon C; Mimouni M; Bricou A; Golfier F; Carcopino X
Eur J Surg Oncol; 2021 May; 47(5):1103-1110. PubMed ID: 33160780
[TBL] [Abstract][Full Text] [Related]
9. Salvage surgery for patients with residual disease after chemoradiation therapy for locally advanced cervical cancer: A systematic review on indication, complications, and survival.
van Kol KGG; Ebisch RMF; Piek JMJ; Zusterzeel PLM; Vergeldt TFM; Bekkers RLM
Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1176-1185. PubMed ID: 33469927
[TBL] [Abstract][Full Text] [Related]
10. Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.
Chakrabarti M; Nordin A; Khodabocus J
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012246. PubMed ID: 36111784
[TBL] [Abstract][Full Text] [Related]
11. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
[TBL] [Abstract][Full Text] [Related]
12. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
Kim JY; Byun SJ; Kim YS; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):34-39. PubMed ID: 27789082
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
Lee SW; Lee SH; Kim J; Kim YS; Yoon MS; Jeong S; Kim JH; Lee J; Eom KY; Jeong BK; Sung SY; Lee SJ; Lee JH
Gynecol Oncol; 2017 Nov; 147(2):334-339. PubMed ID: 28935271
[TBL] [Abstract][Full Text] [Related]
14. Is Surgical Treatment an Option for Locally Advanced Cervical Cancer in the Presence of Central Residual Tumor after Chemoradiotherapy?
Topuz S; Kaban A; Küçücük S; Salihoglu Y
Rev Bras Ginecol Obstet; 2020 Jan; 42(1):35-42. PubMed ID: 32107764
[TBL] [Abstract][Full Text] [Related]
15. EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques.
Vandecasteele K; Tummers P; Van Bockstal M; De Visschere P; Vercauteren T; De Gersem W; Denys H; Naert E; Makar A; De Neve W
BMC Cancer; 2018 Sep; 18(1):898. PubMed ID: 30223802
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
17. The role of completion surgery after concurrent radiochemotherapy in locally advanced stages IB2-IIB cervical cancer.
Chereau E; DE LA Hosseraye C; Ballester M; Monnier L; Rouzier R; Touboul E; Daraï E
Anticancer Res; 2013 Apr; 33(4):1661-6. PubMed ID: 23564812
[TBL] [Abstract][Full Text] [Related]
18. The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.
Valentini AL; Miccò M; Gui B; Giuliani M; Rodolfino E; Telesca AM; Pasciuto T; Testa A; Gambacorta MA; Zannoni G; Rufini V; Giordano A; Valentini V; Scambia G; Manfredi R
Eur Radiol; 2018 Jun; 28(6):2425-2435. PubMed ID: 29318432
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of posttreatment FEDG-PET imaging following combined chemoradiation therapy in locally advanced cervical cancer.
Knight S; Mancini J; Touboul C; Bolze PA; Bendifallah S; Ballester M; Collinet P; Kerbage Y; Ouldamer L; Atrous G; Lavoué V; Dion L; Dabi Y; Raimond E; Graesslin O; Huchon C; Mimouni M; Bricou A; Golfier F; Carcopino X
J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101774. PubMed ID: 32330672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
